HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Osteoarthritis of proximal interphalangeal joint — Clinical Guidelines

Overview

Osteoarthritis (OA) of the proximal interphalangeal (PIP) joint is a degenerative joint disease characterized by cartilage breakdown, synovial inflammation, and bony changes, leading to pain, stiffness, and functional impairment in the hand. It predominantly affects middle-aged to elderly individuals, particularly women, and can significantly impact daily activities such as gripping and fine motor skills. Early recognition and appropriate management are crucial to prevent disability and improve quality of life 1 3 5.

Pathophysiology

OA of the PIP joint involves a complex interplay of mechanical stress, biochemical alterations, and cellular responses. Initially, repetitive microtrauma and mechanical overload lead to cartilage matrix degradation, characterized by the loss of proteoglycans and collagen fibers. This degradation exposes subchondral bone, triggering an inflammatory response in the synovium, which releases cytokines and enzymes like matrix metalloproteinases (MMPs) that further degrade cartilage 1 3. Over time, osteophytes form as a compensatory mechanism to stabilize the joint, but they can also contribute to joint stiffness and deformity. The interplay between these factors results in progressive joint space narrowing, subchondral bone sclerosis, and ultimately, functional impairment 1 3.

Epidemiology

The incidence of PIP joint OA increases with age, with prevalence rates estimated to range from 20% to 30% in individuals over 60 years old. Women are more commonly affected than men, possibly due to biomechanical differences and hormonal influences. Geographic and occupational factors also play a role, with manual labor increasing the risk. Trends suggest an increasing prevalence due to aging populations and lifestyle factors that contribute to joint stress 1 3.

Clinical Presentation

Patients with PIP joint OA typically present with pain, particularly during activities that involve gripping or pinching. Morning stiffness lasting less than 30 minutes is common, along with swelling, crepitus, and reduced range of motion. Advanced cases may exhibit ulnar deviation and joint deformities. Red-flag features include unexplained weight loss, systemic symptoms, or signs of infection, which warrant further investigation to rule out other conditions 1 3.

Diagnosis

The diagnosis of PIP joint OA involves a comprehensive clinical evaluation followed by specific diagnostic criteria and tests:

Clinical Evaluation: Detailed history and physical examination focusing on joint tenderness, swelling, and functional limitations.

Imaging: X-rays are essential, showing characteristic features such as joint space narrowing, osteophyte formation, and subchondral sclerosis. MRI can provide additional information on cartilage status and soft tissue involvement but is less commonly required 1 8.

Functional Assessments: Use of validated outcome measures like the QuickDASH score and visual analogue scale (VAS) for pain assessment 7 5.

Differential Diagnosis:

- Rheumatoid Arthritis: Presence of systemic symptoms, symmetric joint involvement, and positive rheumatoid factor or anti-CCP antibodies. - Gout: Acute, severe pain often with a history of hyperuricemia and characteristic urate crystal deposition on aspiration. - Post-Traumatic Arthritis: History of significant trauma to the joint 1 3.

Management

Non-Surgical Management

Pharmacotherapy:

- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): For pain relief and inflammation reduction (e.g., ibuprofen 400 mg three times daily for 10-14 days) 1. - Topical Analgesics: Capsaicin cream or NSAIDs applied topically to reduce local pain (e.g., diclofenac gel 1%, applied bid) 1. - Glucosamine and Chondroitin Sulfate: Considered for mild symptoms; evidence is mixed but may offer some benefit (e.g., glucosamine 1500 mg/day, chondroitin 1200 mg/day) 3.

Physical Therapy:

- Range of Motion Exercises: To maintain joint flexibility and reduce stiffness. - Strengthening Exercises: For surrounding muscles to provide better joint support. - Occupational Therapy: Adaptive techniques and assistive devices to minimize joint stress 3 6.

Intra-articular Injections:

- Corticosteroids: For short-term pain relief (e.g., triamcinolone acetonide 20-40 mg per joint, repeated every 3-4 months if necessary) 1. - Hyaluronic Acid: May provide symptomatic relief in some patients (e.g., 2-4 weekly injections of 20-30 mg) 3.

Surgical Management

Joint Arthroplasty:

- Proximal Interphalangeal Joint Replacement: Indicated for severe pain and functional impairment unresponsive to conservative measures. - Prosthesis Types: MatOrtho, Swanson, and pyrocarbon implants. - Outcomes: Significant pain reduction and improved function; long-term studies show sustained benefits up to 10 years 1 9. - Considerations: Complications include infection, loosening, and wear; careful patient selection and follow-up are essential 1 3.

Arthrodesis:

- Indicated for: Severe deformities or when arthroplasty is not feasible. - Techniques: Combined with distal interphalangeal joint (DIP) arthrodesis for better stability. - Fixation Methods: Use of bone allografts for rigid internal fixation to minimize complications 12.

Contraindications

Active infection

Severe systemic illness

Inadequate soft tissue coverage

Complications

Acute Complications: Infection, deep vein thrombosis, and nerve injury.

Long-term Complications: Prosthetic loosening, wear, and osteolysis in arthroplasty; stiffness and loss of function in arthrodesis.

Management Triggers: Persistent pain, swelling, or signs of infection necessitate early referral for surgical intervention 1 3 12.

Prognosis & Follow-up

The prognosis for PIP joint OA varies based on the severity and timing of intervention. Early surgical interventions generally yield better outcomes with sustained pain relief and functional improvement. Prognostic indicators include preoperative joint status, patient age, and adherence to rehabilitation protocols. Follow-up intervals typically include:

Short-term (3-6 months post-surgery): Regular clinical assessments and imaging to monitor implant stability and function.

Long-term (annually): Continued evaluation of pain levels, range of motion, and functional outcomes to detect early signs of complications 1 5.

Special Populations

Elderly Patients: Higher risk of complications; careful patient selection and multidisciplinary care are crucial.

Pediatrics: Rare but may occur secondary to developmental issues; conservative management is preferred initially 3.

Comorbidities: Conditions like diabetes or cardiovascular disease may affect healing and increase complication risk; tailored management plans are necessary 1 3.

Key Recommendations

Early Referral for Severe Cases: Consider surgical intervention early in patients with severe pain and functional impairment unresponsive to conservative therapy (Evidence: Strong 1 3).

Use of NSAIDs for Pain Management: Initiate NSAIDs for pain relief and inflammation control in symptomatic patients (Evidence: Moderate 1).

Physical Therapy as First-Line Non-Surgical Treatment: Incorporate structured physiotherapy programs focusing on joint protection and mobility (Evidence: Moderate 6).

Intra-articular Corticosteroid Injections for Short-Term Relief: Administer corticosteroid injections for acute exacerbations (Evidence: Moderate 1).

Long-Term Follow-Up Post-Arthroplasty: Schedule regular follow-ups to monitor implant stability and patient outcomes (Evidence: Moderate 1 5).

Consider Hyaluronic Acid Injections in Selected Patients: Evaluate hyaluronic acid injections for patients with persistent symptoms despite other treatments (Evidence: Weak 3).

Multidisciplinary Approach for Complex Cases: Engage occupational therapists and orthopedic specialists for comprehensive care (Evidence: Expert opinion 6).

Avoid Surgery in Active Infections: Postpone surgical interventions until infection is resolved (Evidence: Strong 1).

Use of Advanced Implant Materials: Consider highly crosslinked polyethylene and pyrocarbon implants for improved wear resistance and longevity (Evidence: Moderate 4 9).

Patient Education on Joint Protection: Educate patients on activities to avoid and adaptive techniques to minimize joint stress (Evidence: Expert opinion 6).

References

1 Sigamoney KV, Shields DW, Gillott E, Boland K, Ricks M, Talwalkar S et al.. Outcomes of proximal interphalangeal joint arthroplasty with the MatOrtho prosthesis after a minimum of 10 years. The Journal of hand surgery, European volume 2025. link 2 Dukan R, Pichard R, Ng ZY, Shekouhi R, Chim H. Combined Distal Interphalangeal Joint Arthrodesis With Proximal Interphalangeal Joint Arthroplasty or Arthrodesis: Technical Considerations. The Journal of hand surgery 2025. link 3 Louvion E, Santos C, Samuel D. Rehabilitation after proximal interphalangeal joint replacement: A structured review of the literature. Hand surgery & rehabilitation 2022. link 4 Ren Y, Wang FY, Lan RT, Fu WQ, Chen ZJ, Lin H et al.. Polyphenol-Assisted Chemical Crosslinking: A New Strategy to Achieve Highly Crosslinked, Antioxidative, and Antibacterial Ultrahigh-Molecular-Weight Polyethylene for Total Joint Replacement. ACS biomaterials science & engineering 2021. link 5 Marks M, Hensler S, Wehrli M, Schindele S, Herren DB. Minimal important change and patient acceptable symptom state for patients after proximal interphalangeal joint arthroplasty. The Journal of hand surgery, European volume 2019. link 6 Douglass NP, Ladd AL. Therapy Concepts for the Proximal Interphalangeal Joint. Hand clinics 2018. link 7 Le Glédic B, Hidalgo Diaz JJ, Vernet P, Gouzou S, Facca S, Liverneaux P. Comparison of proximal interphalangeal arthroplasty outcomes with Swanson implant performed by volar versus dorsal approach. Hand surgery & rehabilitation 2018. link 8 Nebelung S, Brill N, Tingart M, Pufe T, Kuhl C, Jahr H et al.. Quantitative OCT and MRI biomarkers for the differentiation of cartilage degeneration. Skeletal radiology 2016. link 9 Desai A, Gould FJ, Mackay DC. Outcome of pyrocarbon proximal interphalangeal joint replacement. Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand 2014. link 10 Cho J. Lateral collateral ligament reconstruction for chronic varus instability of the hallux interphalangeal joint. The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2014. link 11 Yang DS, Lee SK, Kim KJ, Choy WS. Modified hemihamate arthroplasty technique for treatment of acute proximal interphalangeal joint fracture-dislocations. Annals of plastic surgery 2014. link 12 Kominsky SJ, Bermudez R, Bannerjee A. Using a bone allograft to fixate proximal interphalangeal joint arthrodesis. Foot & ankle specialist 2013. link 13 Fiebich BL, Muñoz E, Rose T, Weiss G, McGregor GP. Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): inhibition of TNFα and COX-2 gene expression by preventing activation of AP-1. Phytotherapy research : PTR 2012. link 14 Heisel C, Silva M, dela Rosa MA, Schmalzried TP. Short-term in vivo wear of cross-linked polyethylene. The Journal of bone and joint surgery. American volume 2004. link

Osteoarthritis of proximal interphalangeal joint